Nine-month results of the BIOHELIX-I clinical trial study: Evaluation of the PRO-Kinetic Energy cobalt chromium bare-metal stent system.

Tesfaldet T MichaelGert RichardtAlexandra J LanksyRobert J CarneyMuhammad Akram KhanAbbas ShehadehUwe ZeymerSaurabh Gupta

Published in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2017)

The 9-month TVF rate of the PKE stent was comparable to other BMS and is a viable option for treating CAD. The low observed rate of ischemia-driven TVR supports the safety and efficacy of the novel BMS design.

Keyphrases

clinical trial
coronary artery disease
open label
double blind
phase iii
gold nanoparticles